Justin Jewell has taken a role as global investment manager at Ninety One after leaving RBC BlueBay last August.

Investing gives you the opportunity to grow your money, to help you get the most out of life, whatever goals you have in mind ...

RBC Capital analysts reaffirmed their Outperform rating on the stock in a note Tuesday, emphasizing that President Trump's recent executive order on wind leasing and permitting is unlikely to have a ...

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...

Investing.com -- RBC Capital Markets has downgraded both Anglo American (JO: AGLJ) plc and Antofagasta (LON: ANTO) plc to ...

The group joining RBC's New York City office, led by advisors formerly affiliated with First Republic, gives it an additional ...

Ninety One, a global investment manager with £130.2 billion AUM (as at 31.12.24), has today announced the appointment of ...

RBC Capital analyst Gerard Cassidy maintained a Buy rating on Regions Financial (RF – Research Report) on January 17 and set a price target of ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price target ...

Tuesday, shares of Carnarvon Energy Ltd (CVN:AU) (OTC: CVONF) experienced a shift in perspective from analysts at RBC Capital ...

Syndax Pharmaceuticals struggles with competitive pressures and market skepticism despite promising drugs and strong cash position. Read more on SNDX here.